Impact of the National Health Service Health Check on cardiovascular disease risk: A difference-in-differences matching analysis

CMAJ

Volumn 188, Issue 10, 2016, Pages E228-E238

  Chang, Kiara Chu Mei ^a   Lee, John Tayu ^a,b   Vamos, Eszter P ^a   Soljak, Michael ^a   Johnston, Desmond ^a   Khunti, Kamlesh ^c   Majeed, Azeem ^a   Millett, Christopher ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^c UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATRIAL FIBRILLATION; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; ETHNICITY; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY HISTORY; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; NATIONAL HEALTH SERVICE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL VASCULAR DISEASE; PREVALENCE; RETROSPECTIVE STUDY; RISK REDUCTION; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; TRANSIENT ISCHEMIC ATTACK; BLOOD; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPLICATION; ENGLAND; FACTUAL DATABASE; GENERAL PRACTICE; MIDDLE AGED; MULTICENTER STUDY; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; ENGLAND; FEMALE; GENERAL PRACTICE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; STATE MEDICINE;

EID: 84978416112     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.151201     Document Type: Article

References (50)

1. Global status report on noncommunicable diseases 2014. Geneva: World Health Organization; 2014.
2. Transforming our world: the 2030 Agenda for Sustainable Development. New York: United Nations, Division for Sustainable Development; 2015. Available: https://sustainabledevelopment.un.org/post2015/transformingourworld (accessed 2015 Sept. 7).
3. Package of Essential Noncommunicable (PEN) disease interventions for primary health care in low-resource settings. Geneva: World Health Organization; 2010.
4. Health targets: more heart and diabetes checks. Wellington (NZ): Government of New Zealand, Ministry of Health; 2014. Available: www.health.govt.nz/new-zealand-health-system/health-targets/about-health-targets/health-targets-more-heart-and-diabetes-checks (accessed 2015 Mar. 24).
5. Frieden TR, Berwick DM. The "Million Hearts" initiative - preventing heart attacks and strokes. N Engl J Med 2011; 365:e27.
6. Cardiovascular diseases [fact sheet]. New Delhi (India): Office of the WHO Representative to India. Available: www.searo.who.int/india/topics/cardiovascular-diseases/CVD-fact-sheet.pdf?ua=1 (accessed 2015 July 16).
7. Smith E; CHHS-AP Steering Committee. Canadian Heart Health Strategy and Action Plan: building a heart healthy Canada. Ottawa: Canadian Heart Health Strategy and Action Plan; 2009.
8. Smith ER The Canadian Heart Health Strategy and Action Plan. Can J Cardiol 2009; 25:451-2.
9. Ponka D. The periodic health examination in adults. CMAJ 2014; 186:1245.
10. Gøtzsche PC, Jørgensen KJ, Krogsbøll LT. Authors' reply to Lauritzen and colleagues, Newton and colleagues, and Mangin. BMJ 2014; 349:g4790.
11. Newton JN, Davis A, Waterall J, et al. NHS Health Check programme: too early to conclude. BMJ 2014; 349:g4785.
12. Gøtzsche PC, Jørgensen KJ, Krogsbøll LT. General health checks don't work. BMJ 2014; 348:g3680.
13. Lauritzen T, Sandbaek A, Borch-Johnsen K. General health checks may work. BMJ 2014; 349:g4697.
14. Forster AS, Dodhia H, Booth H, et al. Estimating the yield of NHS Health Checks in England: a population-based cohort study. J Public Health (Oxf) 2015; 37:234-40.
15. Cochrane T, Davey R, Iqbal Z, et al. NHS health checks through general practice: randomised trial of population cardiovascular risk reduction. BMC Public Health 2012; 12:944.
16. Artac M, Dalton AR, Majeed A, et al. Effectiveness of a national cardiovascular disease risk assessment program (NHS Health Check): results after one year. Prev Med 2013; 57:129-34.
17. Clinical Practice Research Datalink. London (UK): The Clinical Practice Research Datalink Group; 2015. Available: www.cprd.com/intro.asp (accessed 2015 Aug. 20).
18. Lawrenson R, Williams T, Farmer R. Clinical information for research; the use of general practice databases. J Public Health Med 1999; 21:299-304.
19. van Staa TP, Smeeth L, Ng ES, et al. The efficiency of cardiovascular risk assessment: Do the right patients get statin treatment? Heart 2013; 99:1597-602.
20. Herrett E, Gallagher AM, Bhaskaran K, et al. Data resource profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol 2015; 44:827-36.
21. Herrett E, Thomas SL, Schoonen WM, et al. Validation and validity of diagnoses in the General Practice Research Database: a systematic review. Br J Clin Pharmacol 2010; 69:4-14.
22. Putting prevention first. NHS Health Check: vascular risk assessment and management. Best practice guidance. London: National Health Service, Department of Health; 2009.
23. Daykin A, White H. Vascular health check: business rules paper. Version 1.0. In: NHS Health Check secondary use data set, NHS Health Check data set - documentation. West Yorkshire (UK): Health and Social Care Information Centre; 2015. Available: www.hscic.gov.uk/nhshealthcheck (accessed 2015 Aug. 20).
24. Chang KCM, Soljak M, Lee JT, et al. Coverage of a national cardiovascular risk assessment and management programme (NHS Health Check): retrospective database study. Prev Med 2015; 78:1-8.
25. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008; 336:1475-82.
26. Lipid modification: cardiovascular risk assessment and modification of blood lipids for the primary and secondary prevention of cardiovascular disease. London (UK): National Institute for Health and Care Excellence; 2014.
27. Lewis JD, Brensinger C. Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey. Pharmacoepidemiol Drug Saf 2004; 13:437-41.
28. Townsend P, Phillimore P, Beattie A, eds. Health and deprivation. Inequality and the North. London (UK): Croom Helm; 1987.
29. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study. Heart 2008; 94:34-9.
30. Heckman JJ, Ichimura H, Todd PE. Matching as an econometric evaluation estimator: evidence from evaluating a job training programme. Rev Econ Stud 1997; 64:605-54.
31. Smith JA, Todd PE. Does matching overcome LaLonde's critique of nonexperimental estimators? J Econom 2005; 125:305-53.
32. Buscha F, Maurel A, Page L, et al. The effect of employment while in high school on educational attainment: a conditional difference-in-differences approach. Oxf Bull Econ Stat 2012; 74:380-96.
33. Rawat R, Kadiyala S, McNamara PE. The impact of food assistance on weight gain and disease progression among HIV-infected individuals accessing AIDS care and treatment services in Uganda. BMC Public Health 2010; 10:316.
34. Cheng L, Liu H, Zhang Y, et al. The impact of health insurance on health outcomes and spending of the elderly: evidence from China's new cooperative medical scheme. Health Econ 2015; 24: 672-91.
35. Imbens GM, Wooldridge JM. Recent developments in the econometrics of program evaluation. NBER Work Pap 14251. Cambridge (MA): National Bureau of Economic Research; 2008.
36. Kantarevic J, Kralj B. Link between pay for performance incentives and physician payment mechanisms: evidence from the diabetes management incentive in Ontario. Health Econ 2013; 22:1417-39.
37. Blundell R, Costa Dias M. Evaluation methods for non-experimental data. Fisc Stud 2000; 21:427-68.
38. Jones AM, Rice N. Econometric evaluation of health policies. HEDG Work Pap 09/09. York (UK): University of York, Health Economics and Data Group; 2009.
39. Altman DG, Bland JM. Missing data. BMJ 2007; 334:424.
40. Janssen KJ, Donders ART, Harrell FE, et al. Missing covariate data in medical research: to impute is better than to ignore. J Clin Epidemiol 2010; 63:721-7.
41. Sterne JAC, White IR, Carlin JB, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009; 338:b2393.
42. Rubin DB Multiple imputation for nonresponse in surveys. John Wiley & Sons; 2004.
43. Lad M. The English indices of deprivation 2010. London (UK): Department for Communities and Local Government (UK); 2011. Available: www.gov.uk/government/uploads/system/uploads/attachment-data/file/6871/1871208.pdf (accessed 2015 Aug. 20).
44. Si S, Moss JR, Sullivan TR, et al. Effectiveness of general practice-based health checks: a systematic review and meta-analysis. Br J Gen Pract 2014; 64:e47-53.
45. Perry C, Thurston M, Alford S, et al. The NHS health check programme in England: a qualitative study. Health Promot Int 2016; 31:106-15.
46. Ellis N, Gidlow C, Cowap L, et al. A qualitative investigation of non-response in NHS health checks. Arch Public Health 2015; 73:14.
47. Vascular Policy Team. Economic modelling for vascular checks. London (UK): Department of Health; 2008.
48. Capewell S, McCartney M, Holland W. NHS Health Checksa naked emperor? [invited debate]. J Public Health (Oxf) 2015; 37:187-92.
49. Waterall J, Greaves F, Gresser C, et al. Response to Capewell et al. [invited debate]. J Public Health (Oxf) 2015; 37:193-4.
50. Coventry P, Lovell K, Dickens C, et al. Integrated primary care for patients with mental and physical multimorbidity: cluster randomised controlled trial of collaborative care for patients with depression comorbid with diabetes or cardiovascular disease. BMJ 2015; 350:h638.